Molecular biomarkers in interstitial lung diseases. (Q38220769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Molecular biomarkers in interstitial lung diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Angelo De Lauretis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

505-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

Histopathologic diagnosis in diffuse lung disease: an ailing gold standard.

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prevalence and prognosis of unclassifiable interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Disease-modifying treatment in systemic sclerosis: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Outcome measures in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Pulmonary function tests in connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Novel Risk Markers and Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Personalized medicine: applying 'omics' to lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Elevated brain natriuretic peptide predicts mortality in interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Interstitial lung disease in systemic sclerosis: a simple staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow's ear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

A Normal Range of KL-6/MUC1 Independent of Elevated SP-D Indicates a Better Prognosis in the Patients with Honeycombing on High-Resolution Computed Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Biomarkers in connective tissue disease-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Significance of connective tissue diseases features in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Autoimmune-featured interstitial lung disease: a distinct entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Interstitial lung disease in connective tissue disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Fibrocytes in pulmonary fibrosis: a brief synopsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Adult-onset pulmonary fibrosis caused by mutations in telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Telomere shortening in familial and sporadic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Molecular mechanisms in progressive idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Surfactant gene polymorphisms and interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

A common MUC5B promoter polymorphism and pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Genetics and early detection in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveolar lavage in other interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveolar lavage as a research tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Database of bronchoalveolar lavage fluid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Proteomics of bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Proteome Analysis of Bronchoalveolar Lavage Fluid in Lung Fibrosis Associated with Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Proteomics: current techniques and potential applications to lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Predicting survival across chronic interstitial lung disease: the ILD-GAP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Meta-analysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Angiogenic cytokines in patients with idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Frequency and Implication of Autoimmune Serologies in Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Osteopontin in the development of systemic sclerosis--relation to disease activity and organ manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0109-0

Interstitial lung disease in polymyositis and dermatomyositis

21 January 2018

1 reference

12 December 2020

Serum CA 15-3 is increased in pulmonary fibrosis.

1 reference

12 December 2020

Lung epithelium-specific proteins: characteristics and potential applications as markers

1 reference

12 December 2020

High plasma concentrations of osteopontin in patients with interstitial pneumonia

1 reference

12 December 2020

CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study

1 reference

12 December 2020

Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis

1 reference

12 December 2020

KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia

1 reference

12 December 2020

Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis

1 reference

12 December 2020

Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis

1 reference

12 December 2020

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease

1 reference

12 December 2020

Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.

1 reference

12 December 2020

Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis

1 reference

12 December 2020

Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia

1 reference

12 December 2020

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?

1 reference

12 December 2020

Intercellular adhesion molecule-1 in patients with idiopathic interstitial pneumonia

1 reference

12 December 2020

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis

1 reference

12 December 2020

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression

1 reference

12 December 2020

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias

1 reference

12 December 2020

Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia

1 reference

12 December 2020

Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis

1 reference

12 December 2020

High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia

1 reference

12 December 2020

Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia.

1 reference

12 December 2020

Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis

1 reference

12 December 2020

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease

1 reference

12 December 2020

Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease

1 reference

12 December 2020

Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis

1 reference

12 December 2020

[CA 19-9 in patients with benign pulmonary diseases]

1 reference

12 December 2020

Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis

1 reference

12 December 2020

The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis

1 reference

12 December 2020

The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation

1 reference

12 December 2020

Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia

1 reference

12 December 2020

Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis

1 reference

12 December 2020

The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.

1 reference

12 December 2020

Circulating biomarkers of interstitial lung disease in systemic sclerosis

1 reference

12 December 2020

Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?

1 reference

12 December 2020

Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis

1 reference

12 December 2020

Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

[Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia]

1 reference

12 December 2020

CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis

1 reference

12 December 2020

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis

1 reference

12 December 2020

Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis

1 reference

12 December 2020

Proteome analysis of bronchoalveolar lavage fluid in chronic hypersensitivity pneumonitis

1 reference

12 December 2020

Hepatocyte growth factor and idiopathic pulmonary fibrosis

1 reference

12 December 2020

Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?

1 reference

12 December 2020

Serum indicators of free radical activity in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension

1 reference

12 December 2020

Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis.

1 reference

12 December 2020

CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.

1 reference

12 December 2020

Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis

1 reference

12 December 2020

Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases.

1 reference

12 December 2020

S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases

1 reference

12 December 2020

Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

1 reference

12 December 2020

Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis

1 reference

12 December 2020

Serum KL-6 in adult patients with polymyositis and dermatomyositis

1 reference

12 December 2020

CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment

1 reference

12 December 2020

Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases

1 reference

12 December 2020

Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary

1 reference

12 December 2020

Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis

1 reference

12 December 2020

Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis

1 reference

12 December 2020

Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement

1 reference

12 December 2020

Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis

1 reference

12 December 2020

8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis

1 reference

12 December 2020

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

1 reference

12 December 2020

Elevated nocturnal desaturation index predicts mortality in interstitial lung disease

1 reference

12 December 2020

Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?

1 reference

12 December 2020

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

12 December 2020

Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia

1 reference

12 December 2020

BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis

1 reference

12 December 2020

Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects.

1 reference

12 December 2020

Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines

1 reference

12 December 2020

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis

1 reference

12 December 2020

Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent

1 reference

12 December 2020

Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids

1 reference

12 December 2020

Protein traffic across lung epithelia.

1 reference

12 December 2020

Role of interleukin-10 in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers

1 reference

12 December 2020

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.

1 reference

12 December 2020

Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia

1 reference

12 December 2020

Identification of Fibrocytes in Peripheral Blood

1 reference

12 December 2020

Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis

1 reference

12 December 2020

A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker

1 reference

12 December 2020

Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis

1 reference

12 December 2020

10.1007/S40291-014-0109-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 March 2020

1048208208

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24935523%20AND%20SRC:MED&resulttype=core&format=json